English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Correction to: Molecular brain (2015) 8:54 DOI 10.1186/s13041-015-0145-7 In the original publication of this article [1], published on 18 September 2015, it was noticed that the information on a plasmid expressing HA-tagged human p53 gene is wrong. In this Correction the incorrect and correct information on this gene are shown (and marked bold). In the first paragraph of the Methods section, the plasmid expressing HA-tagged human p53 gene is described as followed: Plasmids expressing the HA-tagged human p53 gene (16434) and FLAG-p21 (16240) were purchased from Addgene (Cambridge, MA, USA) and shLRRK2 plasmid specifically inhibiting expression of endogenous human LRRK2 (TI202451) from ORIGENE (Rockville, MD, USA). The correct description of the plasmid expressing HAtagged human p53 gene is: Ha-p53 WT was previously described [2]. FLAG-p21 was purchased from Addgene (#16240, Cambridge, MA, USA) and shLRRK2 plasmid specifically inhibiting expression of endogenous human LRRK2 (TI202451) from ORIGENE (Rockville, MD, USA).

Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression